Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

Delayed Quote. Delayed  - 07/29 08:59:59 am
20.25 GBp   --.--%
06/09 PURICORE : To Submit New Drug Application For PR022 To FDA In 2017
05/27 PURICORE : To Stop Selling ProduceFresh Until Registered As Pesticid..
04/14 PURICORE : Appointment of Dr. Christian Peters as Chief Medical Offi..
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

PuriCore plc : PuriCore Raises $3.5 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/03/2012 | 09:11pm CEST
PuriCore plc ("PuriCore" or the "Company" or the "Group") PuriCore Raises $3.5 Million MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 January 2012 - PuriCore (LSE: PURI), the water- based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that it closed on a new $3.5 million debt facility with Republic Bank on 29 December 2011. The debt will be utilized to finance the working capital requirements associated with Sterilox Fresh and FloraFresh System installations in H1 2012. The facility is structured as a promissory note with an imputed interest rate of 4%. Enquiries:

FTI Consulting Susan Quigley Ben Brewerton

+44 (0) 20 7831 3113

About PuriCore

PuriCoreplc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon controlling contamination, including food retail and foodservice, medical device disinfection, and wound care. PuriCore's solutions are proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of C.difficile, E.coli, HIV, Human and Animal Influenza (including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.

1

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PURICORE PLC
06/09 PURICORE : To Submit New Drug Application For PR022 To FDA In 2017
05/27 PURICORE : To Stop Selling ProduceFresh Until Registered As Pesticide
04/14 PURICORE : Appointment of Dr. Christian Peters as Chief Medical Officer
04/14 PURICORE : Appoints Christian Peters As Chief Medical Officer
03/29 PURICORE : CEO Buys 100,000 Shares (DIRECTOR DEALINGS)
03/29 PURICORE : Good progress
03/29 PURICORE : Good progress Biopharmaceutical company PuriCore,
03/24 PURICORE : Considers Spin-Off Of Supermaket Retail Unit As Revenue Rises
03/01 PURICORE : Appoints Balkrishan Gill To Board As Non-Executive
02/09 PURICORE : stronger Biopharmaceutical company PuriCore
More news
Sector news : Biotechnology & Medical Research - NEC
08:56aDJSanofi Profit Down as Diabetes Drug Sales Slip
07/28DJCELGENE : Lifts Guidance as Revlimid Sales Rise -- Update
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28DJCELGENE : Lifts Guidance as Revlimid Sales Rise
07/27DJVERTEX PHARMACEUTICALS : Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart PURICORE PLC
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Full-screen chart
Managers
NameTitle
John Alexander Martin Chief Executive Officer & Executive Director
Charles Alexander Evan Spicer Non-Executive Chairman
Marella Thorell COO, CFO, Secretary & Executive Director
Christian Peters Chief Medical Officer
Joseph William Birkett Senior Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PURICORE PLC2.53%13
INCYTE CORPORATION-18.75%16 533
CELLTRION, INC.--.--%10 724
LONZA GROUP AG12.20%9 855
QUINTILES TRANSNATIONA..13.49%9 232
ALKERMES PLC-39.37%7 276
More Results